Income Taxes - Schedule of Income Tax Expenses (Details) - USD ($) |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 30, 2025 |
Oct. 31, 2025 |
Oct. 31, 2024 |
Oct. 31, 2023 |
|
| Income Tax Expense (Benefit), Continuing Operations [Abstract] | |||||
| Current income tax expense | $ 354,877 | $ 143,621 | $ 313,463 | $ 370,713 | $ 344,918 |
| Deferred income tax effect | (148,914) | (113,869) | (110,563) | 10,054 | (27,991) |
| Total income tax expense | $ 205,963 | $ 29,752 | $ (202,900) | $ (380,767) | $ (316,927) |
| Effective tax rates | (23.70%) | (6.60%) | (170.10%) | 15.30% | 14.30% |
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|